关于儿科患者囊性纤维化病的最新情况
1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Columbia University Irving Medical Center, 622 West 168th Street, PH 17 East - 105L, New York, NY, 10032, USA. ses2005@cumc.columbia.edu.
Current gastroenterology reports
|August 31, 2023
概括
囊性纤维化 (CF) 管理得到了改进,CFTR调节器疗法提高了肺功能和体重. 需要进一步的研究才能充分了解它们对CF患者胃肠道和肝脏健康的影响.
科学领域:
- 胃肠病学 胃肠病学
- 肺部病理学 肺部病理学
- 遗传学 遗传学 是一个
背景情况:
- 囊性纤维化 (CF) 是一种遗传性多系统性疾病,影响许多器官.
- 胃肠道和肝胆道并发症是CF管理的重大挑战.
研究的目的:
- 审查CF中的营养,胃肠道和肝胆道表现.
- 强调CFTR调节器治疗对这些表现的影响.
主要方法:
- 关于CF胃肠道和肝胆道方面的当前研究的文献综述.
- 对研究CFTR调节器治疗效果的研究分析.
主要成果:
- 由于改善治疗方法,CF患者的预期寿命增加.
- CFTR调节器治疗对肺功能和体重增加有好处.
- 建议提供个性化的营养支持和早期的胰腺干预.
- 建议对肝胆道问题进行非侵入性查.
- 对CFTR调节器对肠道和肝脏健康的全部影响需要进一步调查.
结论:
- CFTR调节器显著提高了生存率和生活质量.
- 目前正在进行的研究对于阐明CFTR调节剂对肠道和肝胆道健康的长期影响至关重要.
- 患者报告的结果和生物标志物是评估调节器疗效的关键.
相关概念视频
Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194
Cystic Fibrosis: Pathogenesis
278
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
278
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K


